UBS Group’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.2M | Buy |
|
|||||
|
2025
Q1 | $9.79M | Buy |
|
|||||
|
2024
Q4 | $7.49M | Buy |
|
|||||
|
2024
Q3 | $5.96M | Sell |
|
|||||
|
2024
Q2 | $5.12M | Buy |
|
|||||
|
2024
Q1 | $4.4M | Buy |
|
|||||
|
2023
Q4 | $405K | Buy |
|
|||||
|
2023
Q3 | $168K | Sell |
|
|||||
|
2023
Q2 | $671K | Buy |
|
|||||
|
2023
Q1 | $6.73K | Hold |
|
|||||
|
2022
Q4 | $3.59K | Buy |
|
|||||
|
2022
Q3 | $4K | Sell |
|
|||||
|
2022
Q2 | $1.38M | Buy |
|
|||||
|
2022
Q1 | $173K | Sell |
|
|||||
|
2021
Q4 | $661K | Sell |
|
|||||
|
2021
Q3 | $3.27M | Sell |
|
|||||
|
2021
Q2 | $8.29M | Buy |
|
|||||
|
2021
Q1 | $9.04M | Sell |
|
|||||
|
2020
Q4 | $12.8M | Buy |
|
|||||
|
2020
Q3 | $1.04M | Sell |
|
|||||
|
2020
Q2 | $1.37M | Buy |
|
|||||
|
2020
Q1 | $163K | Sell |
|
|||||
|
2019
Q4 | $208K | Buy |
|
|||||
|
2019
Q3 | $79K | Buy |
|
|||||
|
2019
Q2 | $2K | Hold |
|
|||||
|
2019
Q1 | $2K | Sell |
|
|||||
|
2018
Q4 | $8K | Sell |
|
|||||
|
2018
Q3 | $107K | Sell |
|
|||||
|
2018
Q2 | $211K | Buy |
|
|||||
|
2018
Q1 | $49K | Buy |
|
|||||
|
2017
Q4 | $26K | Sell |
|
|||||
|
2017
Q3 | $51K | Buy |
|
|||||
|
2017
Q2 | $48K | Sell |
|
|||||
|
2017
Q1 | $70K | Buy |
|
|||||
|
2016
Q4 | $28K | Sell |
|
|||||
|
2016
Q3 | $41K | Buy |
|
|||||
|
2016
Q2 | $19K | Buy |
|
|||||
|
2016
Q1 | $14K | Sell |
|
|||||
|
2015
Q4 | $57K | Buy |
|
|||||
|
2015
Q3 | $52K | Buy |
|
|||||
|
2015
Q2 | $4K | Sell |
|
|||||
|
2015
Q1 | $33K | Buy |
|
|||||
|
2014
Q4 | $13K | Buy |
|